NVST
Price
$20.35
Change
+$0.36 (+1.80%)
Updated
Sep 26 closing price
Capitalization
3.38B
31 days until earnings call
UTMD
Price
$62.81
Change
+$0.37 (+0.59%)
Updated
Sep 26 closing price
Capitalization
201.35M
Interact to see
Advertisement

NVST vs UTMD

Header iconNVST vs UTMD Comparison
Open Charts NVST vs UTMDBanner chart's image
Envista Holdings
Price$20.35
Change+$0.36 (+1.80%)
Volume$1.95M
Capitalization3.38B
Utah Medical Products
Price$62.81
Change+$0.37 (+0.59%)
Volume$6.48K
Capitalization201.35M
NVST vs UTMD Comparison Chart in %
Loading...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVST vs. UTMD commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Buy and UTMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (NVST: $20.35 vs. UTMD: $62.81)
Brand notoriety: NVST and UTMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NVST: 98% vs. UTMD: 57%
Market capitalization -- NVST: $3.38B vs. UTMD: $201.35M
NVST [@Pharmaceuticals: Other] is valued at $3.38B. UTMD’s [@Pharmaceuticals: Other] market capitalization is $201.35M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green whileUTMD’s FA Score has 0 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 0 green, 5 red.
According to our system of comparison, UTMD is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 4 TA indicator(s) are bullish while UTMD’s TA Score has 4 bullish TA indicator(s).

  • NVST’s TA Score: 4 bullish, 4 bearish.
  • UTMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, UTMD is a better buy in the short-term than NVST.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а -2.77% price change this week, while UTMD (@Pharmaceuticals: Other) price change was +1.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

NVST is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($3.38B) has a higher market cap than UTMD($201M). NVST has higher P/E ratio than UTMD: NVST (63.59) vs UTMD (16.75). NVST YTD gains are higher at: 5.495 vs. UTMD (3.806). NVST has more cash in the bank: 1.11B vs. UTMD (82.2M). UTMD has less debt than NVST: UTMD (256K) vs NVST (1.6B).
NVSTUTMDNVST / UTMD
Capitalization3.38B201M1,683%
EBITDA303MN/A-
Gain YTD5.4953.806144%
P/E Ratio63.5916.75380%
Revenue2.55BN/A-
Total Cash1.11B82.2M1,352%
Total Debt1.6B256K623,438%
FUNDAMENTALS RATINGS
NVST vs UTMD: Fundamental Ratings
NVST
UTMD
OUTLOOK RATING
1..100
6769
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9169
PRICE GROWTH RATING
1..100
5451
P/E GROWTH RATING
1..100
4937
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTMD's Valuation (59) in the Medical Specialties industry is in the same range as NVST (73) in the null industry. This means that UTMD’s stock grew similarly to NVST’s over the last 12 months.

UTMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVST (100) in the null industry. This means that UTMD’s stock grew similarly to NVST’s over the last 12 months.

UTMD's SMR Rating (69) in the Medical Specialties industry is in the same range as NVST (91) in the null industry. This means that UTMD’s stock grew similarly to NVST’s over the last 12 months.

UTMD's Price Growth Rating (51) in the Medical Specialties industry is in the same range as NVST (54) in the null industry. This means that UTMD’s stock grew similarly to NVST’s over the last 12 months.

UTMD's P/E Growth Rating (37) in the Medical Specialties industry is in the same range as NVST (49) in the null industry. This means that UTMD’s stock grew similarly to NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTUTMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
56%
Momentum
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
62%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 24 days ago
66%
Bullish Trend 13 days ago
57%
Declines
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
47%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 5 days ago
60%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSMAX34.510.33
+0.97%
Nuveen Small/Mid-Cap Value A
CDDYX37.490.26
+0.70%
Columbia Dividend Income Inst3
IOGPX7.380.04
+0.54%
Voya Global Insights Portfolio S2
FELCX83.670.07
+0.08%
Fidelity Advisor Semiconductors C
MSSLX10.05-0.05
-0.50%
Morgan Stanley Inst Inception L

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with A. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+1.80%
A - NVST
57%
Loosely correlated
+1.23%
MTD - NVST
56%
Loosely correlated
-0.42%
SOLV - NVST
56%
Loosely correlated
+1.29%
XRAY - NVST
55%
Loosely correlated
+2.38%
BIO - NVST
53%
Loosely correlated
+0.35%
More

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with NVST. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
+0.59%
NVST - UTMD
48%
Loosely correlated
+1.80%
ITGR - UTMD
48%
Loosely correlated
-0.27%
INMD - UTMD
46%
Loosely correlated
+0.81%
AVNS - UTMD
45%
Loosely correlated
+1.90%
TMCI - UTMD
45%
Loosely correlated
-0.30%
More